NVO
Live chart
What they do
Novo Nordisk A/S engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas.
For information only · Important disclosures
Grades vs sector
No sector grades for NVO yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.
Our models
Not held by any of our 5 live models right now.
News
More newsKey stats
Valuation and fundamentals
Valuation & fundamentals
Earnings
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | 4.98 | 6.18 | +24.0% |
| 2026-05-05 | 6.96 | 6.63 | -4.8% |
| 2026-02-03 | 5.90 | 6.04 | +2.3% |
| 2025-11-05 | 4.24 | 4.50 | +6.0% |
| 2025-08-06 | 6.00 | 5.96 | -0.7% |
| 2025-05-07 | 6.07 | 6.53 | +7.5% |
| 2025-02-04 | 5.97 | 6.34 | +6.2% |
| 2024-11-06 | 5.92 | 6.12 | +3.4% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $78.5B | +2.1% |
| 2026-03-31 | $96.8B | – |
| 2025-12-31 | $79.1B | – |
| 2025-09-30 | $75.0B | – |
| 2025-06-30 | $76.9B | – |
Analyst actions
PT $40
PT $40
PT $41
PT $74
Recent dividends
Stats refreshed 2026-10-21 18:06:55 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app
Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.
Beta 0.9 · Oct 21, 2026